409 related articles for article (PubMed ID: 19081492)
1. Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus.
Yue Y; Barry PA
Adv Virus Res; 2008; 72():207-26. PubMed ID: 19081492
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of Wild-Type-Like Rhesus Cytomegalovirus Strains following Oral Exposure of Immune-Competent Rhesus Macaques.
Yue Y; Chang WLW; Li J; Nguyen N; Schmidt KA; Dormitzer PR; Yang X; Barry PA
J Virol; 2022 Feb; 96(3):e0165321. PubMed ID: 34788083
[TBL] [Abstract][Full Text] [Related]
3. Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques.
Yue Y; Zhou SS; Barry PA
J Gen Virol; 2003 Dec; 84(Pt 12):3371-3379. PubMed ID: 14645918
[TBL] [Abstract][Full Text] [Related]
4. Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesis.
Sequar G; Britt WJ; Lakeman FD; Lockridge KM; Tarara RP; Canfield DR; Zhou SS; Gardner MB; Barry PA
J Virol; 2002 Aug; 76(15):7661-71. PubMed ID: 12097580
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.
Deere JD; Chang WLW; Villalobos A; Schmidt KA; Deshpande A; Castillo LD; Fike J; Walter MR; Barry PA; Hartigan-O'Connor DJ
Proc Natl Acad Sci U S A; 2019 Jun; 116(26):13036-13041. PubMed ID: 31189602
[TBL] [Abstract][Full Text] [Related]
6. Characterization of rhesus cytomegalovirus genes associated with anti-viral susceptibility.
Swanson R; Bergquam E; Wong SW
Virology; 1998 Jan; 240(2):338-48. PubMed ID: 9454707
[TBL] [Abstract][Full Text] [Related]
7. Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus.
Kolb P; Sijmons S; McArdle MR; Taher H; Womack J; Hughes C; Ventura A; Jarvis MA; Stahl-Hennig C; Hansen S; Picker LJ; Malouli D; Hengel H; Früh K
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487278
[TBL] [Abstract][Full Text] [Related]
8. Characterization and immunological analysis of the rhesus cytomegalovirus homologue (Rh112) of the human cytomegalovirus UL83 lower matrix phosphoprotein (pp65).
Yue Y; Kaur A; Zhou SS; Barry PA
J Gen Virol; 2006 Apr; 87(Pt 4):777-787. PubMed ID: 16528025
[TBL] [Abstract][Full Text] [Related]
9. Exploitation of Interleukin-10 (IL-10) Signaling Pathways: Alternate Roles of Viral and Cellular IL-10 in Rhesus Cytomegalovirus Infection.
Eberhardt MK; Deshpande A; Fike J; Short R; Schmidt KA; Blozis SA; Walter MR; Barry PA
J Virol; 2016 Nov; 90(21):9920-9930. PubMed ID: 27558431
[TBL] [Abstract][Full Text] [Related]
10. Rhesus and human cytomegalovirus glycoprotein L are required for infection and cell-to-cell spread of virus but cannot complement each other.
Bowman JJ; Lacayo JC; Burbelo P; Fischer ER; Cohen JI
J Virol; 2011 Mar; 85(5):2089-99. PubMed ID: 21191007
[TBL] [Abstract][Full Text] [Related]
11. Update on human cytomegalovirus in destructive periodontal disease.
Slots J
Oral Microbiol Immunol; 2004 Aug; 19(4):217-23. PubMed ID: 15209990
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques.
Yue Y; Kaur A; Eberhardt MK; Kassis N; Zhou SS; Tarantal AF; Barry PA
J Virol; 2007 Feb; 81(3):1095-109. PubMed ID: 17108040
[TBL] [Abstract][Full Text] [Related]
13. Plasmablast Response to Primary Rhesus Cytomegalovirus (CMV) Infection in a Monkey Model of Congenital CMV Transmission.
Fan Q; Nelson CS; Bialas KM; Chiuppesi F; Amos J; Gurley TC; Marshall DJ; Eudailey J; Heimsath H; Himes J; Deshpande A; Walter MR; Wussow F; Diamond DJ; Barry PA; Moody MA; Kaur A; Permar SR
Clin Vaccine Immunol; 2017 May; 24(5):. PubMed ID: 28298291
[TBL] [Abstract][Full Text] [Related]
14. Vaccine strategies against human cytomegalovirus infection.
Zhong J; Khanna R
Expert Rev Anti Infect Ther; 2007 Jun; 5(3):449-59. PubMed ID: 17547509
[TBL] [Abstract][Full Text] [Related]
15. Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus.
Fu TM; Wang D; Freed DC; Tang A; Li F; He X; Cole S; Dubey S; Finnefrock AC; ter Meulen J; Shiver JW; Casimiro DR
Vaccine; 2012 Dec; 30(52):7469-74. PubMed ID: 23107592
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
Rölle A; Olweus J
APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
[TBL] [Abstract][Full Text] [Related]
17. Host immune responses to a viral immune modulating protein: immunogenicity of viral interleukin-10 in rhesus cytomegalovirus-infected rhesus macaques.
Eberhardt MK; Chang WL; Logsdon NJ; Yue Y; Walter MR; Barry PA
PLoS One; 2012; 7(5):e37931. PubMed ID: 22655082
[TBL] [Abstract][Full Text] [Related]
18. A seroprevalence study of primate workers for asymptomatic rhesus cytomegalovirus infection.
Bowman JJ; Burbelo PD; Gill RB; Sauri MA; Schmitt JM; Cohen JI
J Clin Virol; 2014 Aug; 60(4):411-3. PubMed ID: 24890818
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of experimental rhesus cytomegalovirus infection.
Lockridge KM; Sequar G; Zhou SS; Yue Y; Mandell CP; Barry PA
J Virol; 1999 Nov; 73(11):9576-83. PubMed ID: 10516066
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of primate models for AIDS.
Haigwood NL
AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
